Table 3.
Control group (n = 531) (%) | Study group (n = 532) (%) | Total (n = 1,052) (%) | |
---|---|---|---|
Dose reduction | |||
(−) | 84.7 | 90.2 | 87.5 |
(+) | 15.3 | 9.8 | 12.5 |
Treatment discontinuation | |||
(−) | 64.0 | 66.4 | 65.2 |
(+) | 36.0 | 33.6 | 34.8 |
Control group (n = 531) (%) | Study group (n = 532) (%) | Total (n = 1,052) (%) | |
---|---|---|---|
Dose reduction | |||
(−) | 84.7 | 90.2 | 87.5 |
(+) | 15.3 | 9.8 | 12.5 |
Treatment discontinuation | |||
(−) | 64.0 | 66.4 | 65.2 |
(+) | 36.0 | 33.6 | 34.8 |